Clinical Trials Sponsored by TESARO/GlaxoSmithKline

Total 4964 results

GlaxoSmithKline

Completed

Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) (IR)

Epilepsy

Bulgaria, Thailand, Russian Federation, Belgium, Italy, Ukraine, France, Germany, Netherlands, Poland
GlaxoSmithKline

Completed

A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Argentina, Canada, Germany, Spain, United States, Italy, Netherlands, South Africa, Sweden, France, Mexico, Australia
GlaxoSmithKline

Completed

A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures

Epilepsy

Thailand, Korea, Republic of, Malaysia
GlaxoSmithKline

Completed

A Study to Investigate Food Occlusion Efficacy of a Denture Adhesive in Denture Wearers

Denture Retention

United States
GlaxoSmithKline

Terminated

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
GlaxoSmithKline

Completed

A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin

Skin Care

Brazil
GlaxoSmithKline

Completed

A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride

Gingivitis

United States
GlaxoSmithKline

Completed

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

Malaria

Senegal, Burkina Faso
GlaxoSmithKline

Completed

A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

Hepatitis B

Germany
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

Infections, Rotavirus | Rotavirus Vaccines

Korea, Republic of
GlaxoSmithKline

Completed

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females

Infections, Papillomavirus

South Africa
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
GlaxoSmithKline

Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Infections, Papillomavirus | Papillomavirus Vaccines

Belgium, United States
GlaxoSmithKline

Completed

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Infections, Papillomavirus | Papillomavirus Vaccines

United States
GlaxoSmithKline

Completed

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Infections, Papillomavirus | Papillomavirus Vaccines

Denmark, Poland, Lithuania
GlaxoSmithKline

Completed

Post Market Surveillance for Infanrix™

Tetanus | Diphtheria | Acellular Pertussis

Korea, Republic of
GlaxoSmithKline

Completed

Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

Lung Cancer, Non-Small Cell

Spain, Estonia, Belgium, Germany, Finland, Latvia, Greece, Netherlands, Italy, Poland, Norway, France, Lithuania, United Kingdom
GlaxoSmithKline

Completed

A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.

Infections, Rotavirus

Dominican Republic, Honduras, Panama, Mexico, Brazil, Argentina, Colombia, Chile, Finland, Nicaragua, Peru, Venezuela
GlaxoSmithKline

Completed

Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children

Infections, Streptococcal

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.

Malaria

Mozambique
GlaxoSmithKline

Terminated

Study of GSK2586881 on Acute Hypoxia and Exercise

Healthy Volunteers

Germany
GlaxoSmithKline

Completed

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Infections, Papillomavirus

Belgium, United States
GlaxoSmithKline

Completed

A Study to Investigate the Impact of Fortified Malt Based on Immunity Outcomes in School Children

Growth and Development

India
GlaxoSmithKline

Completed

To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers

Tobacco Use Disorder

United States
GlaxoSmithKline

Completed

Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents

Anaemia

Japan
GlaxoSmithKline

Completed

Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children

Asthma

Japan, United States, United Kingdom, Poland
GlaxoSmithKline

Completed

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

United States
GlaxoSmithKline

Completed

Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children

Infections, Meningococcal

Finland
GlaxoSmithKline

Completed

Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™

Infections, Streptococcal

Nigeria, Mali
GlaxoSmithKline

Completed

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Prophylaxis Invasive Pneumococcal Diseases and Pneumonia

Belgium
GlaxoSmithKline

Completed

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

Meningococcal Disease | Infections, Meningococcal

United States
GlaxoSmithKline

Completed

Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma

Melanoma

France, Italy, Germany, Netherlands, Switzerland, United Kingdom, Austria, Australia
GlaxoSmithKline

Terminated

Efficacy and Safety of Ambrisentan in Children 8-18yrs

Hypertension, Pulmonary

France, United States, Germany, Spain, Italy, Japan, Hungary, Russian Federation, Argentina
GlaxoSmithKline

Completed

Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years

Asthma

China
GlaxoSmithKline

Completed

A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

Diphtheria

Brazil
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis | Poliomyelitis Vaccines

Philippines
GlaxoSmithKline

Completed

Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

Diphtheria-Tetanus-acellular Pertussis Vaccines

Korea, Republic of
GlaxoSmithKline

Terminated

A Safety Study of GSK3039294 in Healthy Volunteers and Patients With Systemic Amyloidosis

Amyloidosis

United Kingdom
GlaxoSmithKline

Terminated

Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging

Amyloidosis

Sweden
GlaxoSmithKline

Completed

Provoked Craving Assessment

Smoking | Smoking Dependence

United States
GlaxoSmithKline

Completed

Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

Irritable Bowel Syndrome

Australia
GlaxoSmithKline

Completed

Pertussis Infection in Adolescents and Adults With Prolonged Cough

Pertussis

Taiwan, Thailand, Malaysia
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Meningococcal Infection

Mexico, Lebanon
GlaxoSmithKline

Completed

Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])

Streptococcus Agalactiae

South Africa
GlaxoSmithKline

Completed

Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany, United States, South Africa
GlaxoSmithKline

Completed

COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine

Infections, Streptococcal

Argentina, Panama, Colombia
GlaxoSmithKline

Completed

Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)

Asthma

United States, Canada
GlaxoSmithKline

Completed

First Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy Subjects

Hepatitis B

United Kingdom

3

Subscribe